Bradley D Hunter (Bradley Hunter)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

JCO oncology practice

Journal of thrombosis and thrombolysis

Future oncology (London, England)

Expert review of anticancer therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Robert D Siegel, Kristine B LeFebvre, Sarah Temin, Amy Evers, Lisa Barbarotta, Ronda M Bowman, Alexandre Chan, David W Dougherty, Michael Ganio, Bradley D Hunter, Meredith Klein, Tamara P Miller, Therese Marie Mulvey, Amanda Ouzts, Martha Polovich, Maritza Salazar-Abshire, Elaine Z Stenstrup, Christine Marie Sydenstricker, Susan Tsai, MiKaela M Olsen
Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards. JCO oncology practice (2024)
Robert D Siegel, Kristine B LeFebvre, Sarah Temin, Amy Evers, Lisa Barbarotta, Ronda M Bowman, Alexandre Chan, David W Dougherty, Michael Ganio, Bradley D Hunter, Meredith Klein, Tamara P Miller, Therese Marie Mulvey, Amanda Ouzts, Martha Polovich, Maritza Salazar-Abshire, Elaine Z Stenstrup, Christine Marie Sydenstricker, Susan Tsai, MiKaela M Oslen
Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards. JCO oncology practice (2024)
Daanish Hoda, Robert Richards, Edward A Faber, Abhinav Deol, Bradley D Hunter, Elizabeth Weber, Heather DiFilippo, Toni Henderson-Clark, Linda Meaux, Concetta Crivera, Carrie Riccobono, Ashraf Garrett, Carolyn C Jackson, Jessica Fowler, Panteli Theocharous, Raj Stewart, Andrea L Lorden, David L Porter, Ariel Berger
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma. Future oncology (London, England) 18 (19) (2022)
Bradley D Hunter, Daanish Hoda, Andy Nguyen, Launce Gouw, Bryan Huber, Ryan R Jensen, Justine Preedit, Andrew Evens, Esther Huang, Jiyeon Park, Dennis L Cooper
Successful administration of chimeric antigen receptor (CAR) T-cell therapy in patients requiring hemodialysis. Experimental hematology & oncology 11 (1) (2022)
Bradley D Hunter
What are the key considerations for deciding on the use of CAR T-cell therapy for patients with follicular lymphoma? Expert review of anticancer therapy 22 (11) (2022)
Bradley D Hunter, Tracy Minichiello, Stephen Bent
Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review. Journal of thrombosis and thrombolysis 44 (3) (2018)